House may now let go of deliberating medical marijuana bills--Sotto | Inquirer News
As DDB already moved to approve cannabis use for epilepsy

House may now let go of deliberating medical marijuana bills–Sotto

/ 10:43 AM February 18, 2020

sotto

Senate President Vicente Sotto III. (PRIB Photo)

MANILA, Philippines — With the Dangerous Drugs Board (DDB) recently approving “in principle” a resolution authorizing the use of cannabidiol (CBD) for alleviating severe forms of epilepsy, Senate President Vicente Sotto III said Congress should no longer waste its time and efforts legislating a law legalizing the same.

“The DDB move proves that the law being proposed in the HOR (House of Representatives) is unnecessary. There is more important proposed legislation that our honorable counterparts at the HOR should spend their time on,” Sotto said in a statement on Tuesday.

Article continues after this advertisement

“I hope they give priority to measures that will have more impact on the most number of our countrymen,” he added.

FEATURED STORIES

The Senate leader added that he would not raise any objection to DDB’s move to pass “in principle” a resolution allowing the use of CBD, which is a nonpyschoactive component in cannabis.

But Sotto said his support will border on the assumption that the use of such “is in medicine form” and conforms with the guidelines and permit of the DDB-Philippine Drug Enforcement Agency (PDEA).

Article continues after this advertisement

He further pointed out anew that the use of cannabis for medical purposes is already authorized under the country’s Comprehensive Dangerous Drugs Act.

Article continues after this advertisement

The Senate president noted that the said act sets down the policy that “the government shall aim to achieve a balance in the national drug control program so that people with legitimate medical needs are not prevented from being treated with adequate amounts of appropriate medications, which include the use of dangerous drugs.”

The policy is implemented through a circular issued by the Food and Drug Administration (FDA) providing the guidelines for the issuance of a “compassionate special permit,” Sotto noted.

Edited by JPV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Cannabis, House, News, Sotto

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.